TMEM238

Across TCGA pan-cancer cohorts, TMEM238 mass-spec protein differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of TMEM238’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where TMEM238 mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types TMEM238 is over-expressed in tumor, although a few such as COAD and CCRCC show the opposite, repressed pattern.

COAD, CCRCC, and LSCC are the cancer types where TMEM238 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in TMEM238 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	III,IV	−0.332	<.001	11	view →
CCRCC	Female	All	−0.783	<.001	9	view →
LSCC	Female	All	+0.391	.010	1	view →
PDAC	All	All	−0.289	.023	1	view →
LUAD	All	All	+0.134	.015	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

TMEM238–COAD

Open the COAD breakdown →